Risk factors for mechanical ventilation in respiratory syncytial virus infection

1993 ◽  
Vol 152 (2) ◽  
pp. 125-127 ◽  
Author(s):  
W. J. E. Tissing ◽  
H. A. van Steensel-Moll ◽  
M. Offringa
2020 ◽  
Author(s):  
Puneyavee Aikphaibul ◽  
Tuangtip Theerawit ◽  
Jiratchaya Sophonphan ◽  
Noppadol Wacharachaisurapol ◽  
Nattapong Jitrungruengnij ◽  
...  

Author(s):  
Anne M Hause ◽  
Lakshmi Panagiotakopoulos ◽  
Eric S Weintraub ◽  
Lina S Sy ◽  
Sungching C Glenn ◽  
...  

Abstract We identified 10 women hospitalized with respiratory syncytial virus infection during pregnancy. Diagnoses included pneumonia/atelectasis (5), respiratory failure (2), and sepsis (2). Six had obstetrical complications during hospitalization, including 1 induced preterm birth. One required intensive care unit admission and mechanical ventilation. Four infants had complications at birth.


2020 ◽  
Author(s):  
Puneyavee Aikphaibul ◽  
Tuangtip Theerawit ◽  
Jiratchaya Sophonphan ◽  
Noppadol Wacharachaisurapol ◽  
Nattapong Jitrungruengnij ◽  
...  

2008 ◽  
Vol 29 (2) ◽  
pp. 205-210 ◽  
Author(s):  
Giovanni Corsello ◽  
Paola Di Carlo ◽  
Ludovico Salsa ◽  
Bruna Gabriele ◽  
Lidia Meli ◽  
...  

2017 ◽  
pp. 7-10 ◽  
Author(s):  
K. V. YEVDOKIMOV ◽  
V. B. ROVNIY ◽  
I. V. BABACHENKO ◽  
E. V. SHARIPOVA

The review focuses on respiratory syncytial virus infection (RSVI) and, based on the literature and authors' own observations, highlights epidemiological aspects and risk factors for RSVI (including severe forms of the infection), the specific clinical manifestations, challenges of laboratory diagnostics, and the benefits of various methods and their relevance in clinical practice. The available types of RSVI therapies are discussed based on meta-analyses of the data. The authors emphasize the importance of palivizumab in the specific passive prevention of respiratory syncytial virus infection in children from risk groups.


Sign in / Sign up

Export Citation Format

Share Document